UCSF Education for Healthcare Providers on Care and Research During COVID-19
Course video and enrollment

Want to see more like this? View additional CME offerings

Pediatric Specialty Care in the Time of COVID: Managing Blood Disorders and Cancer

To begin the course, play the video below. There is a link below the video to complete the evaluation and post-test if you want to receive credit for this activity.

Starts On: 8/5/2020
Ends On: 8/4/2021
Session Type: Internet Activity Enduring Material
Course Number: MED23088H
Credits: 0.75

For Credit, complete the evaluation and post-test

This activity was recorded on July 16, 2020.

Learning Objectives

  • Understand how Covid-19 has impacted care for children with cancer and blood disorders.
  • Understand risk of Covid-19 related disease in children with cancer and blood disorders.

Faculty & Planning Committee

Robert Goldsby, MD
Professor of Pediatrics
Director, UCSF Survivors of Childhood Cancer Program

Robert Raphael, MD
Associate Professor of Pediatrics

Disclosure of Financial Relationships

Robert Goldsby, MD
Stock Shareholder for Moderna

Robert Raphael, MD
Nothing to Disclose

Accreditation Information

The University of California, San Francisco School of Medicine (UCSF) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

UCSF designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credits™.   Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses: For the purposes of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credit™ issued by organizations accredited by the ACCME.

Physician Assistants: AAPA accepts category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA PRA Category 1 credit™ from organizations accredited by the ACCME.

Pharmacy: The California Board of Pharmacy accepts as continuing professional education those courses that meet the standard of relevance to pharmacy practice and have been approved for AMA PRA Category 1 Credits™.